Nuclear Energy Market Recovery and Investment Opportunities
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 04 2026
0mins
Should l Buy SMR?
Source: Fool
- Market Recovery: The International Atomic Energy Agency (IAEA) forecasts that global nuclear capacity could expand by up to 2.6 times from 2024 to 2050, reflecting a growing demand for reliable and efficient power, which may present a favorable opportunity for investors.
- NuScale Power Development: NuScale Power focuses on small modular reactors (SMRs), with its 50 MWe and 77 MWe designs receiving Standard Design Approvals from the U.S. Nuclear Regulatory Commission in 2023 and 2025, respectively, which is expected to drive future revenue growth.
- GE Vernova Diversification: GE Vernova's Power and Electrification segments benefited from rapid expansion in the cloud and data center markets over the past year, with revenue and adjusted EBITDA projected to grow at CAGRs of 15% and 54% from 2025 to 2028.
- Investment Outlook: Despite NuScale's high market valuation, analysts expect its annual revenue to triple from $88 million in 2026 to $287 million in 2028, indicating significant future growth potential, making it a compelling stock to consider buying now.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SMR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SMR
Wall Street analysts forecast SMR stock price to rise
13 Analyst Rating
5 Buy
6 Hold
2 Sell
Hold
Current: 10.260
Low
18.50
Averages
32.77
High
60.00
Current: 10.260
Low
18.50
Averages
32.77
High
60.00
About SMR
NuScale Power Corporation is a provider of proprietary advanced small modular reactor nuclear technology. The NuScale Power Module, the Company's SMR technology, is a small pressurized water reactor that can generate 77 megawatts of electricity (MWe) or 250 megawatts thermal (gross) and can be scaled to meet customer needs through an array of flexible configurations of up to 924 MWe (12 modules) of output. In addition to the sale of NPMs, it offers a diversified suite of services throughout the development and operating life of the power plant. The Company's suite of services is planned to include licensing support, testing, training, fuel supply services and program management, among others. It serves a range of customers consisting of governments, political subdivisions, state-owned enterprises, investor-owned utilities and other technology and industrial companies, both in domestic and international markets.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Market Potential: NuScale anticipates that the global small modular reactor market could reach $5.2 billion by 2035, and if it maintains its first-mover advantage, it could generate billions in annual revenue over the next decade, highlighting its strategic significance in the nuclear energy sector.
- Revenue Growth Expectations: Analysts forecast NuScale's revenue to surge from $31 million in 2025 to $331 million by 2028, reflecting strong demand for its front-end engineering design and licensing deals, despite its current market cap of $3.2 billion and a high P/E ratio of 38.
- Technological Innovation Advantage: NuScale's small modular reactor design is highly modular and can be assembled on-site, reducing the costs and complexities of building a nuclear power plant, which has attracted investor interest and aligns with the global resurgence in nuclear energy demand.
- Investor Sentiment Volatility: Although NuScale's stock has plummeted 80% over the past six months, from a high of $53.43 last October to around $10, this pullback may present a buying opportunity for long-term investors, especially as its potential for reactor deployment remains unrealized.
See More
- Nuclear Renaissance Outlook: Analysts from Bank of America highlight a nuclear renaissance driven by surging electricity demand, estimating the total potential value of this sector could reach $10 trillion, indicating significant investment opportunities in nuclear energy.
- NuScale Power Status: NuScale Power's market cap has fallen to $3.7 billion, with shares down approximately one-third since the beginning of the year; despite its small modular reactor (SMR) technology not yet being widely adopted, there remains potential for substantial future growth.
- Oklo's Market Advantage: With a market cap of $9 billion, Oklo is valued significantly higher than NuScale and has established extensive partnerships with major tech companies, with its first reactor expected to be deployed by 2027, showcasing strong execution capabilities in the nuclear sector.
- Investment Risks and Opportunities: While NuScale faces delays in customer agreements, Oklo's buy rating and $127 price target suggest investor optimism about the nuclear industry's future, particularly as AI drives increased electricity demand.
See More

- Legal Investigation Initiated: Faruq & Faruqi, LLP is investigating potential claims against NuScale Power Corporation, particularly for investors who purchased or acquired securities between May 13, 2025, and November 6, 2025, indicating a focus on investor rights.
- Investor Contact Information: The firm encourages investors who suffered losses during the specified period to contact partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) to discuss their legal options, demonstrating a commitment to client service.
- Class Action Reminder: Faruq & Faruqi reminds investors that April 20, 2026, is the deadline to seek the role of lead plaintiff in a federal securities class action filed against NuScale, emphasizing the urgency of legal proceedings.
- Securities Law Expertise: As a leading national securities law firm, the investigation by Faruq & Faruqi suggests that NuScale may face legal challenges, urging investors to act promptly to protect their rights, reflecting potential implications for the company's future stock price.
See More
- Ostin Technology Group Lawsuit: Ostin Technology Group faces a class action lawsuit for alleged securities fraud, with charges against its CEO and financial advisor for orchestrating a scheme that netted over $110 million in illicit proceeds, resulting in shareholders losing over $950 million and a 94% drop in market value on June 26, 2025.
- Fraudulent Securities Offerings: Beginning in April 2025, Ostin's management transferred the majority of shares to co-conspirators through fraudulent securities offerings, causing the stock price to soar from $0.78 to $9.40, with market capitalization exceeding $1 billion, but this artificial inflation led to significant investor losses when the truth emerged.
- NuScale Power Lawsuit: NuScale Power is accused in a class action of failing to disclose that its partnership with ENTRA1 Energy LLC lacked substantial operational experience, exposing its commercialization strategy to significant risks, resulting in investor damages once the reality was revealed.
- Law Firm Involvement: Bragar Eagel & Squire, P.C. serves as the representative law firm, reminding investors to apply as lead plaintiffs before the deadlines to ensure their rights are protected.
See More
- PayPal Lawsuit Overview: During the period from February 2024 to February 2026, PayPal is accused of overstating its business execution capabilities, leading to investor misconceptions about the company's prospects, which is expected to negatively impact its stock price.
- NuScale Power Risk Disclosure: NuScale is charged with failing to disclose significant risks related to its commercialization strategy during the period from May to November 2025, which could undermine investor confidence in its nuclear projects and affect future financing capabilities.
- Corcept Therapeutics Regulatory Issues: From October 2024 to December 2025, Corcept is accused of not disclosing FDA concerns regarding the effectiveness assessment of its drug, which may lead to significant obstacles in future drug approvals, impacting company operations.
- Navan IPO Controversy: During its IPO in 2025, Navan is charged with failing to disclose a 39% increase in sales and marketing expenses, which could mislead investors about its financial health and affect its market performance.
See More
- Stock Price Decline: NuScale Power's stock has plummeted 80% from its record high of $53.43 per share last October to about $10 today, causing significant pain for investors who rushed in, yet it may present a buying opportunity for long-term investors.
- Innovative Design Advantage: NuScale's small modular reactors (SMRs), which received approval from the Nuclear Regulatory Commission, boast a 77 MW capacity and are designed for smaller power plants, reducing the costs and complexities associated with nuclear power plant construction, thereby attracting investor interest.
- Diverse Revenue Sources: Currently, NuScale generates revenue primarily through front-end engineering and design (FEED) studies for a 462 MW plant in Romania and has agreed to deploy up to 6 GW of SMR capacity across seven states for the Tennessee Valley Authority, although these projects won't come online until the early 2030s.
- Significant Market Potential: Analysts project NuScale's revenue to surge from $31 million in 2025 to $331 million in 2028, and if it achieves these estimates, it will still appear reasonably valued at ten times its 2028 sales, positioning it to capture a significant share of the global SMR market projected to be worth $5.2 billion by 2035.
See More










